India is soon likely to participate in the WHO's "solidarity trial" for developing potential drugs for COVID-19, officials said on Friday.
At a press briefing on coronavirus at 4 pm, Health Ministry Joint Secretary Lav Agarwal said 75 new cases of coronavirus and four deaths have been reported in the last 24 hours.
"We are soon likely to participate in the WHO solidarity trial for developing potential drugs for COVID-19. Earlier we did not do it because our numbers were small and our contribution would have looked minuscule," Raman R Gangakhedkar, Head of Epidemiology and Communicable diseases at ICMR, said.
Agarwal said that